Absci (NASDAQ:ABSI) on Thursday announced a collaboration with Oracle Cloud Infrastructure (NYSE:ORCL) and AMD (NASDAQ:AMD) to accelerate its AI-driven drug discovery efforts. As part of the ...

Absci (ABSI) announced a collaboration with Oracle Cloud Infrastructure (ORCL) and AMD (AMD) to accelerate generative AI-driven drug discovery.

Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costsAUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 ...

Absci, a clinical-stage biotech company advancing therapeutics with generative AI, today - Read more from Inside HPC & AI News.

AUSTIN, Texas, Sept. 10, 2025 /PRNewswire/ -- For the third consecutive year, Oracle has been named a Leader in the Gartner® Magic Quadrant™ for Distributed Hybrid Infrastructure. Oracle is positioned ...

Oracle Health is using its data and technology muscle to move out ahead in the healthcare AI arms race. | Oracle Health ...

AUSTIN, Texas, April 25, 2025 /PRNewswire/ -- North York General Hospital (NYGH) in Toronto, Canada, has improved the performance and usability of its Oracle Health Foundation electronic health record ...

Oracle today announced the 12c release of its Cloud Application Foundation, an integrated middleware platform for computing across conventional and cloud environments. This release includes a major ...